Revenue: The sum of all revenue fields included for a company's operating activities.
Tibet Pharmaceuticals Inc. (TBET) had Revenue of $32.36M for the most recently reported fiscal year, ending 2010-12-31.
| Income Statement Financials | |
|
Revenue |
$32.36M |
$13.14M |
|
$16.19M |
|
$16.17M |
|
$19.05M |
|
$13.31M |
|
$-0.17M |
|
$13.14M |
|
$13.14M |
|
$13.14M |
|
$13.10M |
|
$13.10M |
|
$13.14M |
|
$13.31M |
|
$14.21M |
|
11.80M |
|
11.80M |
|
$1.11 |
|
$1.11 |
|
| Balance Sheet Financials | |
$21.12M |
|
$6.16M |
|
$7.06M |
|
$28.19M |
|
$4.71M |
|
-- |
|
-- |
|
$4.71M |
|
$23.46M |
|
$22.88M |
|
$23.48M |
|
-- |
|
| Cash Flow Statement Financials | |
$7.85M |
|
$-0.15M |
|
$-4.55M |
|
$4.08M |
|
$7.57M |
|
$3.49M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
49.97% |
|
41.13% |
|
41.13% |
|
43.91% |
|
40.61% |
|
40.61% |
|
$7.70M |
|
-- |
|
-- |
|
-- |
|
1.15 |
|
13.61 |
|
323.60 |
|
1.13 |
|
55.84% |
|
57.26% |
|
46.47% |
|
55.79% |
|
-- |
|
$0.65 |
|
$0.67 |
|